Touyun Biotech Group Limited (HKG:1332)

Touyun Biotech Group Statistics

Total Valuation

HKG:1332 has a market cap or net worth of HKD 482.62 million. The enterprise value is 1.07 billion.

Market Cap	482.62M
Enterprise Value	1.07B

Important Dates

The last earnings date was Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:1332 has 2.81 billion shares outstanding. The number of shares has increased by 0.53% in one year.

Current Share Class	2.81B
Shares Outstanding	2.81B
Shares Change (YoY)	+0.53%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	39.62%
Owned by Institutions (%)	0.00%
Float	1.69B

Valuation Ratios

The trailing PE ratio is 37.14.

PE Ratio	37.14
Forward PE	n/a
PS Ratio	7.21
PB Ratio	17.62
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	39.88
EV / Sales	15.96
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.17, with a Debt / Equity ratio of 18.72.

Current Ratio	0.17
Quick Ratio	0.03
Debt / Equity	18.72
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.84

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-6.43%
Return on Invested Capital (ROIC)	-11.24%
Return on Capital Employed (ROCE)	-212.86%
Weighted Average Cost of Capital (WACC)	3.33%
Revenue Per Employee	144,022
Profits Per Employee	57,632
Employee Count	465
Asset Turnover	0.11
Inventory Turnover	2.37

Taxes

In the past 12 months, HKG:1332 has paid 11,000 in taxes.

Income Tax	11,000
Effective Tax Rate	0.02%

Stock Price Statistics

The stock price has decreased by -3.91% in the last 52 weeks. The beta is -0.32, so HKG:1332's price volatility has been lower than the market average.

Beta (5Y)	-0.32
52-Week Price Change	-3.91%
50-Day Moving Average	0.15
200-Day Moving Average	0.15
Relative Strength Index (RSI)	57.97
Average Volume (20 Days)	9,478,984

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1332 had revenue of HKD 66.97 million and earned 26.80 million in profits. Earnings per share was 0.01.

Revenue	66.97M
Gross Profit	16.22M
Operating Income	-60.14M
Pretax Income	47.57M
Net Income	26.80M
EBITDA	-46.84M
EBIT	-60.14M
Earnings Per Share (EPS)	0.01

Balance Sheet

The company has 5.06 million in cash and 512.68 million in debt, with a net cash position of -507.61 million or -0.18 per share.

Cash & Cash Equivalents	5.06M
Total Debt	512.68M
Net Cash	-507.61M
Net Cash Per Share	-0.18
Equity (Book Value)	27.39M
Book Value Per Share	-0.02
Working Capital	-493.10M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	13.31M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 24.22%, with operating and profit margins of -89.81% and 40.02%.

Gross Margin	24.22%
Operating Margin	-89.81%
Pretax Margin	71.04%
Profit Margin	40.02%
EBITDA Margin	-69.94%
EBIT Margin	-89.81%
FCF Margin	n/a

Dividends & Yields

HKG:1332 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.53%
Shareholder Yield	-0.53%
Earnings Yield	5.55%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 12, 2019. It was a reverse split with a ratio of 0.25.

Last Split Date	Aug 12, 2019
Split Type	Reverse
Split Ratio	0.25

Scores

Altman Z-Score	n/a
Piotroski F-Score	1